The Medical Laboratory Testing and Analysis Services (FSS-621-II) Federal Supply Schedule contract vehicle supports comprehensive diagnostic and clinical laboratory testing services across multiple federal agencies. The vehicle enables government healthcare organizations to procure specialized medical testing capabilities, including genomic screening, reference laboratory testing, molecular diagnostics, cancer screening, and specimen transport services. Task orders under this schedule primarily focus on advanced diagnostic testing methodologies, with an emphasis on precision medicine, specialized cancer screening, and reference laboratory capabilities that supplement in-house medical testing resources. The task orders demonstrate consistent engagement from agencies like the Department of Veterans Affairs, Defense Health Agency, Indian Health Service, and other federal healthcare programs. Prime contractors frequently include Laboratory Corporation of America (LabCorp), Quest Diagnostics, Exact Sciences Corp, and Mdxhealth, with contract values typically ranging from $15,000 to $3,377,163. Most awards are firm fixed-price delivery orders or Blanket Purchase Agreement calls, with performance periods spanning from several months to five years. The contract vehicle consistently shows no set-aside designations, indicating open competition among large diagnostic services providers. Geographically, task orders cover nationwide medical service networks, with particular concentration on Veterans Integrated Service Networks (VISNs) across different regional healthcare systems.
Name | Description | Awardee | Potential Value (Click to sort descending) | Award Date (Click to sort descending) | Last Date To Order (Click to sort descending) | Updated At (Click to sort descending) |
|---|---|---|---|---|---|---|
V797D50532-70CDCR21A00000002 | Laboratory Corporation Of America | $12.5m | 9/28/21 | 9/29/26 | 12/13/24 | |
V797D70090 | Quest Diagnostics Incorporated | $750.0m | 4/1/17 | 3/31/27 | 5/17/24 | |
V797P7105A-DJB60902BPA08002 | Quest Diagnostics Clinical Laboratories, Inc. | $8.4k | 10/1/07 | 9/30/08 | 9/26/07 | |
V797D70090-36C25921A0030 | Quest Diagnostics Incorporated | $349.0k | 4/1/21 | 9/30/22 | 3/10/22 | |
V797P7105A-VA26317A0053 | Quest Diagnostics Incorporated | $11.5m | 11/1/16 | 10/31/21 | 4/12/21 |
Name | Description | Awardee | Potential Value (Click to sort descending) | Award Date (Click to sort descending) | Completion Date (Click to sort descending) | Updated At (Click to sort descending) |
|---|---|---|---|---|---|---|
Delivery Order V797D70090-75N90019F00149 | Quest Diagnostics Incorporated | $118.0k | 6/26/19 | 6/26/24 | 7/25/23 | |
BPA Call HHSI248201700012B-75H71318F29084 | Quest Diagnostics Incorporated | $8.2k | 9/6/18 | 3/31/22 | 9/6/18 | |
BPA Call NND12AA43Z-NND13AB61D | Quest Diagnostics Incorporated | $3.7k | 4/30/13 | 9/30/13 | 11/7/13 | |
Delivery Order V797P7105A-DJBP0614RB110124 | Quest Diagnostics Incorporated | $43.9k | 12/1/15 | 10/31/16 | 10/5/16 | |
BPA Call DJBP0700NASBPA095A-15B30321FWB130022 | Quest Diagnostics Incorporated | $60.2k | 10/1/20 | 9/30/21 | 10/4/21 |
Name | Description | UEI | Primary NAICS | Division | Location | Registration Date (Click to sort descending) | Expiration Date (Click to sort descending) |
|---|---|---|---|---|---|---|---|
| CDX Diagnostics, Inc. | YNN3KFC3DJV3 | 621511 | Not listed | 2 Executive Blvd #102, Montebello, NY 10901, USA | 1/11/19 | 5/29/25 | |
| Pacific Edge Diagnostics USA LTD |
--
| CG7CHPEW8U47 | 621511 | Not listed | 1214 Research Blvd #2000, Hummelstown, PA 17036, USA | 12/4/13 | 12/20/25 |
| American Molecular Laboratories Inc. | KC67JG2WTWZ1 | 621511 | Not listed | 50 Lakeview Pkwy #127, Vernon Hills, IL 60061, USA | 12/8/17 | 1/13/26 | |
| Phamatech, Incorporated | NTBNTF5W31H5 | 621511 | Not listed | 15175 Innovation Dr, San Diego, CA 92128, USA | 2/17/04 | 3/13/25 | |
| Renalytix AI, Inc. |
--
| XJCME3U1FPB5 | 621511 | Not listed | Not listed | 4/9/20 | 11/29/24 |
A Portfolio Platform of GovExec © 2025